Search

"The Power of Hormones: The New Science of How Hormones Impact Every Aspect of Our Health" by Max Nieuwdorp, translated by Alice Tetley-Paul, explores the role of hormones in our bodies. The book explains that hormones are signaling molecules that travel through our blood and bodily fluids to initiate or inhibit biological processes. It delves into how hormones impact digestion, behavior, and even memory. Nieuwdorp presents scientific research to demonstrate the wide-ranging effects of hormones. [Extracted from the article]

The article discusses the high performance liquid chromatography (HPLC) method used in sensitive analysis of the lactose content of lactose-free labeled products. It examines the effectiveness of the method to differentiate sugars such as sucrose and glucose. Also mentioned is the effect of lactose intolerance in digesting lactose caused by enzyme lactase deficiency.

The article offers information on collagen crosslinking technology (CXL) for the treatment of patients suffering from a corneal disease keratoconus and its other applications. It mentions the implementation of CXL technology for successful and keratoconus transplants. It also states that the CXL process helps in dissolving digestive enzymes produced by bacteria and fungi in infectious keratitis.

The article offers information on projects which showed the roles of bacteria that cohabit the human bodies in health and diseases. It states that human microbiome is responsible in performing essential functions like protecting the body from persistent pathogens, building essential vitamins as well as providing digestive enzymes that the body needs to break down plant fibers for energy. It also mentions several projects which aim to map the diversity and activities of the microbial family.

The article focuses on weight management ingredients, which helps consumers to eat less. It mentions ingredients including fiber which reduces calories and lipid oxidation, proteins which maintains lean muscles and lipids which reduces hunger pangs. It states on carbohydrates which inhibits fat cell hypertrophy and botanicals which inhibits digestive enzymes such as lipase and amylase. The Caravan Ingredients Inc. offers weight management premix that promotes satiety through various ingredients.

El artículo reporta que el enfoque de los consumidores se está desplazando hacia el consumo de ingredientes digestivos para mejorar su salud digestiva. Presenta las opiniones de diversos funcionarios de salud sobre el cambio de los hábitos de consumo incluido Julián Mellentin de New Nutrition Business y Katrien Lambeens de Beneo GmbH.

The article offers information on pancreatic enzyme products (PEP), extracts from hog's pancreas that contain lipase, amylase and protease. PEP are indicated for patients with cystic fibrosis and for people with chronic pancreatitis. Overview of studies on the efficacy and clinical application of PEP is offered. It is noted that standardization of PEP is needed to avoid substitution with generic enzymes that commonly result to treatment failures.

The article focuses on the prevalent use of dietary enzymes in swine diets to improve nutrient digestibility in the U.S. swine market. Enzymes, like proteases, lipases and phytases, are biologically active proteins that break specific chemical bonds to release nutrients for further digestion and absorption. The prevalent use of dietary enzymes in swine diets is due to the increasing price of feeds.

Reports that two enzyme companies have launched amylases for the fast-growing ethanol fuel market. Cooking of grains with thermostable enzymes; Operation of alpha amylases.

The article discusses a study by Daniel G. Vassão at the Max Planck Institute for Chemical Ecology, in the periodical "Angewandte Chemie International Edition" in 2014 which revealed that insects digestive enzyme deactivate plant toxin benzoxazinoids with single stereochemical change.

The article discloses the role of digestive enzymes of cows in providing efficient biofuel, which is performed by Joint Genome Institute of the U.S. Department of Energy.

The article reports on the deal of Lonza AG to manufacture liprotamase, a product of Alnara Pharmaceuticals Inc., at its site in Kouřim, Czech Republic. It states that liprotamase, is a pancreatic enzyme replacement therapy for pancreatic insufficiency of patients. It also mentions that the said deal allows Lonza to have access to technology and has the refusal right with regards to the commercial manufacture of products.